HPV DNA as a Biomarker in Oropharyngeal Cancer: A Step in the Right Direction.
A Dimitrios ColevasPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Lack of prospectively planned follow-up and minimal characterization of the patient population studied complicate interpretation of circulating human papillomavirus (HPV) DNA as a prognostic biomarker for patients with HPV-associated oropharyngeal carcinoma treated with curative intent. See related article by Berger et al., p. 4292.